Osimertinib(Tagrix) 40mg & 80mg -(Osimertinib)

Product Name : Osimertinib(Tagrix)
Generic Name : Osimertinib
Formulation : Tablet
Available Pack Size : 30’s
Available Strengths : 40mg & 80mg
Registrations : 01/01/2021
Category:

Product Description

Tagrix 80mg (Osimertinib) What is Beacon?

  • Tagrix 80mg contains the main active ingredient Osimertinib mesylate, available in tablet form, which is indicated for use mainly in the targeted treatment of non-small cell lung cancer. The drug Tagrix 80mg (Osimertinib) Beacon has been tested and used in many countries, including Vietnam.

Basic information

  • Active ingredient: Osimertinib mesylate.
  • Drug class: Anticancer drugs, protein kinase inhibitors.
  • Trade name:  Tagrix 80
  • Dosage form: Tablets.
  • Packaging:  Box of 30 tablets.
  • Origin:  Bangladesh.

Ingredients 

  • Osimertinib mesylate - 80mg
  • Excipients 1 capsule.

What should be avoided when taking Tagrix 80mg?

  • When taking the drug, in addition to using it as prescribed by the treating doctor, it is necessary to limit the use of processed foods with a lot of fat and preservatives, in addition, pay attention to abstain from the use of carbonated food drinks, containing alcohol. Alcohol, stimulants such as alcohol, beer, cigarettes, etc.

Preserve

  • Store at a temperature not exceeding 30°C.
  • Avoid sunlight.
  • Keep out of reach of children.
Substitute of Tagrix
  • Osimert 80mg
  • Osimib 80mg
  • Osicent 80mg
  • Tagrisso 80mg
  • Tagrisso 40mg
  • Luciosim 80mg

Osimertinib (Tagrix) is the 1st and only drug of its kind approved by USFDA for the treatment of epidermal growth factor receptor (EGFR) positive Non- Small Cell Lung Cancer (NSCLC) patients with T790M mutation.

简体中文繁體中文NederlandsEnglishFrançaisDeutschItalianoLatviešu valodaLietuvių kalbaEspañolTürkçeУкраїнська